Clinical Trial Update: Effect on Adrenal Function of Budesonide Versus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing budesonide versus fluticasone in chronic obstructive pulmonary disease has completed, focusing on adrenal function safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Flovent (fluticasone propionate)
• Pulmicort (budesonide)

Snippet

Sponsor: Hull University Teaching Hospitals NHS Trust | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED